A blood test could predict who benefits from immunotherapy
A test which detects changing levels of tumour fragments in the blood may be an easy, non-invasive and quick way to predict who will benefit from immunotherapy, a treatment option for advanced cancers. Although immunotherapy has been shown to shrink tumours and prolong survival for patients for whom other treatments have failed, about 20-30% of…